The PE Ratio as of November 2024 (TTM) for AgeX Therapeutics, Inc. (AGE) is -0.02

According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.53% compared to the average of -1.56 of the last 4 quarters.

AgeX Therapeutics, Inc. (AGE) Historical PE Ratio (quarterly & annually)

How has AGE PE Ratio performed in the past?

The mean historical PE Ratio of AgeX Therapeutics, Inc. over the last ten years is -6.62. The current -0.02 PE Ratio has changed -65.26% with respect to the historical average. Over the past ten years (40 quarters), AGE's PE Ratio was at its highest in in the March 2024 quarter at -0.82. The PE Ratio was at its lowest in in the March 2018 quarter at -103.75.

AgeX Therapeutics, Inc. (AGE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AgeX Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AgeX Therapeutics, Inc. (AGE) Average PE Ratio

How has AGE PE Ratio performed in the past?

The current PE Ratio of AgeX Therapeutics, Inc. (AGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AgeX Therapeutics, Inc. (AGE) PE Ratio vs. Peers

How is AGE’s PE Ratio compared to its peers?

AgeX Therapeutics, Inc.’s PE Ratio is greater than MAIA Biotechnology, Inc. (-1.92), greater than Larimar Therapeutics, Inc. (-6.07), greater than Graphite Bio, Inc. (-0.13), greater than Lyra Therapeutics, Inc. (-0.13), greater than Lineage Cell Therapeutics, Inc. (-4.73), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.18), greater than ImmuCell Corporation (-0.04), greater than Oxford Nanopore Technologies plc (-4.48), less than Praxis Precision Medicines, Inc. (0), greater than Foghorn Therapeutics Inc. (-9.32), greater than Synaptogenix, Inc. (-5.38), greater than Invivyd, Inc. (-0.42), greater than Biohaven Pharmaceutical Holding Company Ltd. (-0.37), greater than Immunome, Inc. (-5.35), greater than Inhibrx Biosciences, Inc. (-1.94), less than Icosavax, Inc. (0.13), greater than null (-15.78),

Build a custom stock screener for AgeX Therapeutics, Inc. (AGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AgeX Therapeutics, Inc. (AGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.